FR2903695B1 - Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents
Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennentInfo
- Publication number
- FR2903695B1 FR2903695B1 FR0606415A FR0606415A FR2903695B1 FR 2903695 B1 FR2903695 B1 FR 2903695B1 FR 0606415 A FR0606415 A FR 0606415A FR 0606415 A FR0606415 A FR 0606415A FR 2903695 B1 FR2903695 B1 FR 2903695B1
- Authority
- FR
- France
- Prior art keywords
- ampap
- activator
- preparing
- pharmaceutical compositions
- compositions containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0606415A FR2903695B1 (fr) | 2006-07-13 | 2006-07-13 | Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
AT07725977T ATE517621T1 (de) | 2006-07-13 | 2007-06-12 | Verwendung von ampk-aktivierenden imidazol- derivaten, herstellungsverfahren dafür und diese enthaltende pharmazeutische zusammensetzungen |
DK07725977.8T DK2040702T3 (da) | 2006-07-13 | 2007-06-12 | Anvendelse af AMPK-aktiverende imidazolderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater omfattende dem |
PL07725977T PL2040702T3 (pl) | 2006-07-13 | 2007-06-12 | Zastosowanie pochodnych imidazolowych aktywujących ampk, sposób ich otrzymywania i kompozycje farmaceutyczne zawierające takie pochodne |
US12/373,310 US8329738B2 (en) | 2006-07-13 | 2007-06-12 | Use of AMPK-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them |
PCT/EP2007/005164 WO2008006432A1 (fr) | 2006-07-13 | 2007-06-12 | Utilisation de dérivés d'imidazole activateurs d'ampk, procédé de préparation de ces composés, et compositions pharmaceutiques pourvues de ceux-ci |
AU2007272082A AU2007272082B2 (en) | 2006-07-13 | 2007-06-12 | Use of AMPK-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them |
ES07725977T ES2367852T3 (es) | 2006-07-13 | 2007-06-12 | Uso de derivados de imidazol que activan ampk, proceso para la preparación de los mismos y composiciones farmacéuticas que los comprenden. |
PT07725977T PT2040702E (pt) | 2006-07-13 | 2007-06-12 | Utilização de derivados imidazole ativadores de ampk, seu processo de preparação e composições farmacêuticas que os compreendem |
EP07725977A EP2040702B1 (fr) | 2006-07-13 | 2007-06-12 | Utilisation de dérivés d'imidazole activateurs d'ampk, procédé de préparation de ces composés, et compositions pharmaceutiques pourvues de ceux-ci |
JP2009518732A JP5237941B2 (ja) | 2006-07-13 | 2007-06-12 | Ampk活性化イミダゾール誘導体の使用、その調製方法およびそれらを含む医薬組成物 |
CA2657335A CA2657335C (fr) | 2006-07-13 | 2007-06-12 | Utilisation de derives d'imidazole activateurs d'ampk, procede de preparation de ces composes, et compositions pharmaceutiques pourvues de ceux-ci |
ARP070103120A AR061994A1 (es) | 2006-07-13 | 2007-07-13 | Uso de derivados de imidazol activadores de ampk, su proceso de preparacion y composiciones farmaceuticas que los comprenden |
IL196280A IL196280A (en) | 2006-07-13 | 2008-12-30 | Ampk-activating imidazole derivatives, processes for their preparation, uses thereof and pharmaceutical compositions comprising them |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0606415A FR2903695B1 (fr) | 2006-07-13 | 2006-07-13 | Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2903695A1 FR2903695A1 (fr) | 2008-01-18 |
FR2903695B1 true FR2903695B1 (fr) | 2008-10-24 |
Family
ID=37696444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0606415A Active FR2903695B1 (fr) | 2006-07-13 | 2006-07-13 | Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Country Status (14)
Country | Link |
---|---|
US (1) | US8329738B2 (fr) |
EP (1) | EP2040702B1 (fr) |
JP (1) | JP5237941B2 (fr) |
AR (1) | AR061994A1 (fr) |
AT (1) | ATE517621T1 (fr) |
AU (1) | AU2007272082B2 (fr) |
CA (1) | CA2657335C (fr) |
DK (1) | DK2040702T3 (fr) |
ES (1) | ES2367852T3 (fr) |
FR (1) | FR2903695B1 (fr) |
IL (1) | IL196280A (fr) |
PL (1) | PL2040702T3 (fr) |
PT (1) | PT2040702E (fr) |
WO (1) | WO2008006432A1 (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2025674A1 (fr) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament |
EP2285786B1 (fr) * | 2008-06-16 | 2013-10-09 | Merck Patent GmbH | Dérivés de quinoxalinedione |
FR2933694B1 (fr) * | 2008-07-10 | 2016-10-21 | Oreal | Utilisation de phenoxyalkylamines dans des compositions cosmetiques et/ou dermatologiques. |
MX2011003239A (es) * | 2008-09-26 | 2011-04-28 | Merck Sharp & Dohme | Nuevos derivados de bencimidazol ciclicos utiles como agentes anti-diabeticos. |
CA2741125A1 (fr) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Nouveaux derives de benzimidazole cycliques utiles comme agents anti-diabetiques |
WO2010051206A1 (fr) | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Nouveaux agents antidiabétiques utiles avec des dérivés de benzimidazole cycliques |
JP2013047189A (ja) * | 2009-12-25 | 2013-03-07 | Kyorin Pharmaceutical Co Ltd | 新規パラバン酸誘導体及びそれらを有効成分とする医薬 |
US8895596B2 (en) | 2010-02-25 | 2014-11-25 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
WO2011107494A1 (fr) | 2010-03-03 | 2011-09-09 | Sanofi | Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation |
WO2011121109A1 (fr) | 2010-04-02 | 2011-10-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Procédés et compositions comprenant un activateur (metformine/troglitazone) d'ampk pour le traitement d'une dystrophie myotonique de type 1 (dm1) |
EP2582709B1 (fr) | 2010-06-18 | 2018-01-24 | Sanofi | Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
JP2013230986A (ja) * | 2010-08-25 | 2013-11-14 | Kyorin Pharmaceutical Co Ltd | 新規ヒダントイン誘導体及びそれらを有効成分とする医薬 |
CA2812109A1 (fr) | 2010-09-20 | 2012-03-29 | Kareus Therapeutics, Sa | Procedes et compositions pour le traitement du diabete et de la dyslipidemie |
US9005909B2 (en) | 2011-01-06 | 2015-04-14 | Rigel Pharmaceuticals, Inc. | Whole blood assay for measuring AMPK activation |
EP2677869B1 (fr) | 2011-02-25 | 2017-11-08 | Merck Sharp & Dohme Corp. | Nouveaux dérivés d'azabenzimidazole cyclique utiles en tant qu'agents antidiabétiques |
WO2013037390A1 (fr) | 2011-09-12 | 2013-03-21 | Sanofi | Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase |
EP2567959B1 (fr) | 2011-09-12 | 2014-04-16 | Sanofi | Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase |
EP2760862B1 (fr) | 2011-09-27 | 2015-10-21 | Sanofi | Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique utilisés comme inhibiteurs de kinase |
PL223830B1 (pl) | 2012-04-03 | 2016-11-30 | Univ Jagielloński | Pochodne aromatycznych imidazolidynonów i ich zastosowanie |
US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
EP2887807B1 (fr) | 2012-08-22 | 2019-09-18 | Merck Sharp & Dohme Corp. | Dérivés de benzimidazole hexahydrofuro[3,2-b]furane en tant qu'activateurs de la protéine kinase activée par l'amp |
AU2013306030A1 (en) | 2012-08-22 | 2015-02-05 | Merck Sharp & Dohme Corp. | Novel azabenzimidazole hexahydrofuro(3,2-b)furan derivatives |
EP2888008B1 (fr) | 2012-08-22 | 2018-12-26 | Merck Sharp & Dohme Corp. | Nouveaux dérivés d'azabenzimidazole tétrahydrofurane |
US9382243B2 (en) | 2012-08-22 | 2016-07-05 | Merck Sharp & Dohme Corp. | Azabenzimidazole tetrahydropyran derivatives |
WO2014031445A1 (fr) | 2012-08-22 | 2014-02-27 | Merck Sharp & Dohme Corp. | Nouveaux dérivés de benzimidazole tétrahydropyrane |
US9540364B2 (en) | 2012-08-22 | 2017-01-10 | Merck Sharp & Dohme Corp. | Benzimidazole tetrahydrofuran derivatives |
SI2946780T1 (sl) * | 2013-01-15 | 2017-05-31 | Fujifilm Corporation | Tableta, ki vsebuje 5-hidroksi-1h-imidazol-4-karboksamid |
WO2014139388A1 (fr) | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Nouveaux dérivés d'indole utiles en tant qu'agents antidiabétiques |
JP6064062B2 (ja) | 2013-03-15 | 2017-01-18 | ファイザー・インク | Ampkを活性化させるインダゾール化合物 |
US10143703B2 (en) | 2014-01-02 | 2018-12-04 | Massachusetts Eye And Ear Infirmary | Treating ocular neovascularization |
EP3355876A2 (fr) | 2015-09-30 | 2018-08-08 | Instituto de Medicina Molecular | Procédés pour atténuer la virulence de parasites |
CN108689939A (zh) * | 2017-04-07 | 2018-10-23 | 厦门华绰生物医药科技有限公司 | 取代咪唑盐类化合物、其制备方法、药用组合物及其应用 |
CA3178994A1 (fr) | 2020-05-19 | 2021-11-25 | Iyassu Sebhat | Activateurs d'ampk |
CN116390925A (zh) | 2020-06-26 | 2023-07-04 | 卡尔优普公司 | Ampk活化剂 |
WO2022072397A1 (fr) | 2020-09-30 | 2022-04-07 | Bioverativ Therapeutics Inc. | Activateurs d'ampk et procédés d'utilisation associés |
WO2022106892A1 (fr) | 2020-11-17 | 2022-05-27 | Instituto De Medicina Molecular | Composés antipaludiques |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4140788A (en) | 1976-11-10 | 1979-02-20 | Sumitomo Chemical Company, Limited | N-Substituted imidazolecarboxamide derivatives |
JPS5379778A (en) | 1976-12-24 | 1978-07-14 | Shimizu Construction Co Ltd | Manufacture of mat made of granule |
JPS5748971A (en) * | 1980-09-08 | 1982-03-20 | Sumitomo Chem Co Ltd | Novel alkylimidazole derivative |
US6482844B1 (en) * | 2000-04-07 | 2002-11-19 | Neurogen Corporation | 1-benzylimidazole derivatives |
WO2002009726A1 (fr) | 2000-07-31 | 2002-02-07 | Trustees Of Boston University | Procedes de traitement des affections asociees a la resistance a l'insuline avec l'aicar, (5-amino-4-imidazole carboxamide riboside) et de composes apparentes |
DE10150172A1 (de) * | 2001-10-11 | 2003-04-30 | Morphochem Ag | Neue Verbindungen, die Protein Tyrosin Phosphatase 1B (PTP-1B) inhibieren |
FR2846656B1 (fr) | 2002-11-05 | 2004-12-24 | Servier Lab | Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US7119205B2 (en) | 2003-05-16 | 2006-10-10 | Abbott Laboratories | Thienopyridones as AMPK activators for the treatment of diabetes and obesity |
JP2005089384A (ja) | 2003-09-18 | 2005-04-07 | Kao Corp | 持久力向上剤 |
JP5339664B2 (ja) | 2004-02-13 | 2013-11-13 | 花王株式会社 | Ampk活性化剤 |
-
2006
- 2006-07-13 FR FR0606415A patent/FR2903695B1/fr active Active
-
2007
- 2007-06-12 AU AU2007272082A patent/AU2007272082B2/en active Active
- 2007-06-12 CA CA2657335A patent/CA2657335C/fr active Active
- 2007-06-12 DK DK07725977.8T patent/DK2040702T3/da active
- 2007-06-12 EP EP07725977A patent/EP2040702B1/fr active Active
- 2007-06-12 US US12/373,310 patent/US8329738B2/en active Active
- 2007-06-12 WO PCT/EP2007/005164 patent/WO2008006432A1/fr active Application Filing
- 2007-06-12 AT AT07725977T patent/ATE517621T1/de active
- 2007-06-12 JP JP2009518732A patent/JP5237941B2/ja active Active
- 2007-06-12 PT PT07725977T patent/PT2040702E/pt unknown
- 2007-06-12 ES ES07725977T patent/ES2367852T3/es active Active
- 2007-06-12 PL PL07725977T patent/PL2040702T3/pl unknown
- 2007-07-13 AR ARP070103120A patent/AR061994A1/es unknown
-
2008
- 2008-12-30 IL IL196280A patent/IL196280A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
AU2007272082A1 (en) | 2008-01-17 |
CA2657335C (fr) | 2015-01-27 |
EP2040702A1 (fr) | 2009-04-01 |
ES2367852T3 (es) | 2011-11-10 |
DK2040702T3 (da) | 2011-09-05 |
WO2008006432A1 (fr) | 2008-01-17 |
CA2657335A1 (fr) | 2008-01-17 |
FR2903695A1 (fr) | 2008-01-18 |
AR061994A1 (es) | 2008-08-10 |
ATE517621T1 (de) | 2011-08-15 |
IL196280A0 (en) | 2009-09-22 |
IL196280A (en) | 2013-02-28 |
EP2040702B1 (fr) | 2011-07-27 |
US8329738B2 (en) | 2012-12-11 |
JP5237941B2 (ja) | 2013-07-17 |
PL2040702T3 (pl) | 2011-11-30 |
AU2007272082B2 (en) | 2012-05-24 |
JP2009542734A (ja) | 2009-12-03 |
US20090253764A1 (en) | 2009-10-08 |
PT2040702E (pt) | 2011-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2903695B1 (fr) | Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
FR2909379B1 (fr) | Nouveaux derives heterocycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
FR2920773B1 (fr) | Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
IL216741A (en) | History of imidazolidine-2-van 1,3-imaging modalities as 17-cyp inhibitors, pharmaceutical preparations containing them, and their use in the preparation of drugs for the treatment of diseases | |
IL203142A (en) | Anti-B antibody CD79, pharmaceuticals including them, their use and method of preparation | |
IL221770A (en) | Edamantyl acetamide derivatives, the pharmaceutical composition containing them and its use in the preparation of a drug | |
ZA200810481B (en) | Benzimidazole derivatives, method for the production thereof, their use as FXR agonists and pharmaceutical preparations containing the same | |
IL192442A0 (en) | Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors | |
EP2142549A4 (fr) | Dérivés d'adénosine, procédé pour la synthèse de ces derniers, et compositions pharmaceutiques pour la prévention et le traitement de maladies inflammatoires contenant lesdits dérivés en tant qu'ingrédients actifs | |
FR2885129B1 (fr) | Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation. | |
FR2903404B1 (fr) | Nouveaux derives tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
FR2883876B1 (fr) | Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
IL197452A0 (en) | New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7 | |
FR2885616B1 (fr) | Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
FR2920774B1 (fr) | Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant | |
FR2872164B1 (fr) | Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent | |
FR2881138B1 (fr) | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
FR2907451B1 (fr) | "nouveaux derives indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent" | |
FR2873377B1 (fr) | Derives d'azasucre, inhibiteurs d'heparanases, leur procede de preparation, les compositions en contenant et leur utilisation | |
FR2885615B1 (fr) | Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
FR2877338B1 (fr) | Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
PT1873140E (pt) | Novos derivados naftalénicos, processo para a sua preparação e composições farmacêuticas que os contenham | |
FR2907452B1 (fr) | "nouveaux derives indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent" | |
FR2897060B1 (fr) | Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant | |
HUP0401524A2 (en) | New benzoyl urea derivatives, process for their preparation, their use and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 13 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
PLFP | Fee payment |
Year of fee payment: 16 |
|
PLFP | Fee payment |
Year of fee payment: 17 |
|
PLFP | Fee payment |
Year of fee payment: 18 |